Document:

EX-10.98

 Exhibit 10.98 
 CONSENT AGREEMENT 
 THIS CONSENT AGREEMENT (this
“Agreement”), dated as of October 5, 2015, is made by US AIRWAYS, INC., a corporation organized and existing under the laws of the State of Delaware, United States of America (“US Airways”), AMERICAN AIRLINES,
INC., a corporation organized and existing under the laws of the State of Delaware, United States of America (“American”), and AIRBUS S.A.S., organized and existing under the laws of the Republic of France
(“Airbus”). 
 WHEREAS, Airbus and US Airways are parties to (i) that certain Amended and Restated
Airbus A350 XWB Purchase Agreement, dated as of October 2, 2007 (together with all exhibits, schedules, supplements, and letter agreements thereto, each as amended, restated, amended and restated, supplemented or otherwise modified from time to
time, the “A350 Agreement”), (ii) that certain Amended and Restated Airbus A320 Family Aircraft Purchase Agreement, dated as of October 2, 2007 (together with all exhibits, schedules, supplements, and letter agreements
thereto, each as amended, restated, amended and restated, supplemented or otherwise modified from time to time, the “A320 Agreement”) and (iii) that certain Airbus A330 Purchase Agreement, dated as of October 2, 2007
(together with all exhibits, schedules, supplements, and letter agreements thereto, each as amended, restated, amended and restated, supplemented or otherwise modified from time to time, the “A330 Agreement”) (each of the A350
Agreement, the A320 Agreement and the A330 Agreement is referred to in this Agreement individually as a “Purchase Agreement” and collectively as the “Purchase Agreements”, and capitalized terms used but not defined
herein shall have the respective meanings given them in the Purchase Agreements);  
 WHEREAS, Airbus and US
Airways are parties to that certain [*CTR];  
 WHEREAS, US Airways is a wholly-owned subsidiary of US Airways
Group, Inc. (“Group”), and Group and American are each a wholly-owned subsidiary of American Airlines Group Inc.; 
 WHEREAS, US Airways is to be merged with and into American, with American being the surviving entity (the “Merger”); 

WHEREAS, Clause 20.2 of each Purchase Agreement provides that US Airways will be entitled to assign its rights under such Purchase
Agreement at any time due to a merger involving US Airways, provided US Airways first obtains the written consent of Airbus; and 
 WHEREAS, Paragraph 4 of the [*CTR] provides that US Airways may not assign or transfer its rights and/or obligations thereunder in any manner without the prior written consent of Airbus.

 NOW, THEREFORE, IT IS AGREED AS FOLLOWS: 

Section 1. Assumption. American (a) agrees for the benefit of Airbus that, as of the effective time of the Merger,
American will assume and undertake all of the liabilities and obligations of the Buyer, whenever accrued, pursuant to each Purchase Agreement and the [*CTR], and (b) confirms that, as of the effective time of the Merger, American (i) shall
be 

  
 [*CTR] =
[CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT] 

 
deemed a party to each Purchase Agreement and the [*CTR], (ii) shall be deemed the party named as the “Buyer” for all purposes of each Purchase Agreement and the [*CTR] and
(iii) shall be bound by, and shall perform and observe, all of the terms of each Purchase Agreement and the [*CTR] as if therein named the Buyer. American agrees that, reasonably promptly following the effective time of the Merger, it will
provide written confirmation to Airbus that the effective time of the Merger has occurred. 
 Section 2.
Representations and Warranties. American hereby represents and warrants to Airbus that: 
 (a)
American is, and at the effective time of the Merger will be, a corporation duly incorporated and validly existing under the laws of the State of Delaware; 
 (b) at the effective time of the Merger, American will be the surviving entity in the Merger; 
 (c) at the effective time, and immediately following the consummation, of the Merger, no Termination Event will exist or will have occurred and be continuing; 

(d) at the effective time of the Merger, there will not exist with respect to American any basis for a Termination Event
within the meaning of Clause 21 of any of the Purchase Agreements; and 
 (e) American holds, and at the
effective time of and immediately following the consummation of the Merger will hold, an air carrier operating certificate issued by the FAA. 
 Section 3. Consent. In consideration of the foregoing, on the date hereof and at the effective time of the Merger:  

(a) pursuant to Clause 20.2 of each Purchase Agreement, Airbus hereby (i) consents to the assignment by US Airways to
American at the effective time of the Merger of all of the rights and obligations of US Airways under each Purchase Agreement and (ii) accepts the assumption by American at the effective time of the Merger of the liabilities and obligations of
the Buyer under each Purchase Agreement; and 
 (b) pursuant to Paragraph 4 of the [*CTR], Airbus hereby
(i) consents to the assignment by US Airways to American at the effective time of the Merger of all of the rights and obligations of US Airways thereunder and (ii) accepts the assumption by American at the effective time of the Merger of
the liabilities and obligations of the Buyer under the [*CTR]. 
 Section 4. Notices. Following the effective
time of the Merger, the Buyer’s address for notices given to the Buyer under any Purchase Agreement or the [*CTR] will be:  
  

	 	Address:	 American Airlines, Inc. 

	 	    	 4333 Amon Carter Boulevard 

	 	    	 Mail Drop 5569 

	 	    	 Fort Worth, Texas 76155 

	 	    	 United States of America 

  

	 	Tel:	 +1 817 967-0405 

	 	Fax:	 +1 817 967-2199 

	 	Email:	 peter.warlick@aa.com 

	 	Attention:	 Vice President – Fleet Planning 

  

	 	cc:	 Assistant Corporate Secretary 

  

					
		  	2	  	Consent Agreement

 [*CTR] =
[CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT] 

 Section 5. Miscellaneous. 

(a) This Agreement shall be binding upon and inure to the benefit of the parties and their respective successors and
permitted assigns. 
 (b) This Agreement will not be amended or modified except by an instrument in writing of
even date herewith or subsequent hereto executed by both parties or by their fully authorized representatives. 

(c) THIS AGREEMENT WILL, PURSUANT TO NEW YORK GENERAL OBLIGATIONS LAW SECTION 5-1401, BE GOVERNED BY AND CONSTRUED AND THE
PERFORMANCE THEREOF WILL BE DETERMINED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK, WITHOUT GIVING EFFECT TO ITS CONFLICTS OF LAWS PROVISIONS THAT WOULD RESULT IN THE APPLICATION OF THE LAW OF ANY OTHER JURISDICTION. 

(d) Each party (i) hereby irrevocably submits itself to the nonexclusive jurisdiction of the courts of the state of
New York in New York County and, to the extent permitted by applicable law, of the United States District Court for the Southern District of New York, for the purposes of any suit, action or other proceeding arising out of this Agreement or any of
the transactions contemplated hereby brought by any party or parties hereto, and (ii) hereby waives, and agrees not to assert, by way of motion, as a defense, counterclaim or otherwise, in any such suit, action or proceeding, to the extent
permitted by applicable law, the defense of sovereign immunity, any claim that it is not personally subject to the jurisdiction of the above-named courts by reason of sovereign immunity or otherwise or that it or its property is exempt or immune
from jurisdiction of such court or from legal process (whether through service of notice, attachment prior to judgment, attachment in aid of execution or judgment, execution of judgment or otherwise) and, to the extent permitted by applicable law,
that the suit, action or proceeding which is referred to in clause (i) above is brought in an inconvenient forum, that the venue of such suit, action or proceeding is improper, or that this Agreement or the subject matter hereof or any of the
transactions contemplated hereby may not be enforced in or by these courts. 
 [Signature page follows.] 

  

					
		  	3	  	Consent Agreement

 [*CTR] =
[CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT] 

 IN WITNESS WHEREOF, the parties hereto have caused this Consent Agreement to be duly
executed as of the day and year first above written. 
  

			
	US AIRWAYS, INC.
		
	By:	 	/s/ Peter Warlick
		 	 Name: Peter Warlick
 Title:
Vice President – Fleet Planning

	
	AMERICAN AIRLINES, INC.
		
	By:	 	/s/ Peter Warlick
		 	 Name: Peter Warlick
 Title:
Vice President – Fleet Planning

	
	AIRBUS S.A.S.
		
	By:	 	/s/ Christophe Mourey
		 	 Name: Christophe Mourey

Title: Senior Vice President Contracts

  
 [*CTR] =
[CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT]Exhibit

        

EXHIBIT 10.5

FIRST AMENDMENT
FIRST AMENDMENT, dated as of October 23, 2015 (this “Amendment”), to the Credit Agreement, dated as of April 10, 2015 (as amended, supplemented or otherwise modified from time to time, the “Credit Agreement”), among (i) BOSTON SCIENTIFIC CORPORATION, a Delaware corporation (the “Borrower”), (ii) the several banks and other financial institutions from time to time parties thereto (the “Lenders”), (iii) BANK OF AMERICA, N.A., as Syndication Agent (the “Syndication Agent”), (iv) BARCLAYS BANK PLC, BNP PARIBAS, CITIBANK N.A., DEUTSCHE BANK SECURITIES INC., ROYAL BANK OF CANADA and SUMITOMO MITSUI BANKING CORPORATION, as Documentation Agents (each in such capacity, a “Documentation Agent”, and collectively, the “Documentation Agents”), and (v) JPMORGAN CHASE BANK, N.A., as Administrative Agent for the Lenders thereunder (in such capacity, the “Administrative Agent”).
W I T N E S S E T H:
WHEREAS, the Borrower, the Lenders, the Syndication Agent, the Documentation Agents and the Administrative Agent are parties to the Credit Agreement; and
WHEREAS, the Borrower has requested that the Lenders amend the Credit Agreement as set forth herein; and
WHEREAS, the Lenders and the Administrative Agent are willing to agree to such amendment to the Credit Agreement, subject to the terms and conditions set forth herein;
NOW, THEREFORE, in consideration of the premises and mutual covenants contained herein, the Borrower, the Lenders and the Administrative Agent hereby agree as follows:
SECTION 1.Defined Terms.  Terms defined in the Credit Agreement and used herein shall have the meanings given to them in the Credit Agreement.
SECTION 2.    Amendment to the Credit Agreement. Clause (g) of the definition of “Consolidated EBITDA” is hereby amended by adding after the phrase “$2,000,000,000 after the Closing Date” therein the phrase “(excluding any amounts (not to exceed in the aggregate $300,000,000) paid after the Closing Date pursuant to the February 13, 2015 settlement agreement with Johnson & Johnson and the other parties thereto relating to certain litigation among Johnson & Johnson, Guidant Corporation, the Borrower, and Abbott Laboratories)”.
SECTION 3.    Conditions to Effectiveness.  This Amendment shall become effective on the date (the “Amendment Effective Date”) on which (a) the Borrower, the Administrative Agent and the Majority Lenders shall have executed and delivered to the Administrative Agent this Amendment and (b) all fees and expenses payable to the Administrative Agent, the other agents and any Lender shall have been paid.
SECTION 4.    Representation and Warranties.  To induce the Administrative Agent to enter into this Amendment, the Borrower hereby represents and warrants to the Administrative Agent and all of the Lenders as of the Amendment Effective Date that: 

2

(a)    Corporate Power; Authorization; Enforceable Obligations. 
(i)    The Borrower has the corporate power and authority, and the legal right, to make and deliver this Amendment and to perform the Loan Documents, as amended by this Amendment, to which it is a party and has taken all necessary corporate action to authorize the execution, delivery and performance of this Amendment and the performance of the Loan Documents, as so amended, to which it is a party.
(ii)    No consent or authorization of, filing with (other than the Borrower’s public filing of the Amendment on Form 8-K, if applicable), or notice to or other act by or in respect of, any Governmental Authority or any other Person is required with respect to the Borrower or any of its Subsidiaries in connection with the execution and delivery of this Amendment or with the performance, validity or enforceability of the Loan Documents, as amended by this Amendment, to which the Borrower is party.
(iii)    This Amendment has been duly executed and delivered on behalf of the Borrower.
(iv)    This Amendment and each Loan Document, as amended by this Amendment, to which the Borrower is a party constitutes a legal, valid and binding obligation of the Borrower enforceable against the Borrower in accordance with its terms, subject to the effects of bankruptcy, examination, insolvency, fraudulent conveyance, reorganization, moratorium and other similar laws relating to or affecting creditors’ rights generally, general equitable principles (whether considered in a proceeding in equity or at law) and an implied covenant of good faith and fair dealing.
(b)    Representations and Warranties.  The representations and warranties (except for those made in subsections 6.13 and 6.14 of the Credit Agreement) made by the Borrower in or pursuant to the Loan Documents are true and correct in all material respects on and as of the Amendment Effective Date, after giving effect to the effectiveness of this Amendment, as if made on and as of the Amendment Effective Date.
SECTION 5.    Payment of Expenses.  The Borrower agrees to pay or reimburse the Administrative Agent for all of its reasonable and documented out-of-pocket costs and expenses incurred in connection with this Amendment, any other documents prepared in connection herewith and the transactions contemplated hereby, including, without limitation, the reasonable and documented fees and disbursements of counsel to the Administrative Agent.
SECTION 6.    No Other Amendments; Confirmation.  Except as expressly amended, modified and supplemented hereby, the provisions of the Credit Agreement and the other Loan Documents are and shall remain in full force and effect.
SECTION 7.    Governing Law; Counterparts. 
(a)    This Amendment and the rights and obligations of the parties hereto shall be governed by, and construed and interpreted in accordance with, the laws of the State of New York.  The provisions of subsections 13.11, 13.12 and 13.17 of the Credit Agreement are incorporated herein, mutatis mutandis.

3

(b)    This Amendment may be executed by one or more of the parties to this Amendment on any number of separate counterparts (including by facsimile transmission or in electronic (i.e., “pdf” or “tif”) format), and all of said counterparts taken together shall be deemed to constitute one and the same instrument.
SECTION 8.    Miscellaneous. 
(a)    Upon and after the Amendment Effective Date, each reference in the Credit Agreement to “this Agreement”, “hereunder”, “hereof” or words of like import referring to the Credit Agreement, and each reference in the other Loan Documents to “the Credit Agreement”, “thereunder”, “thereof” or words of like import referring to the Credit Agreement, shall mean and be a reference to the Credit Agreement as modified hereby.  This Amendment shall constitute a Loan Document.
(b)    The execution, delivery and effectiveness of this Amendment shall not, except as expressly provided herein, operate as a waiver of any right, power or remedy of any Lender or the Agent under any of the Loan Documents, nor, except as expressly provided herein, constitute a waiver or amendment of any provision of any of the Loan Documents. 

IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be duly executed and delivered by their respective proper and duly authorized officers as of the day and year first above written.
BOSTON SCIENTIFIC CORPORATION

By: /s/ Robert Castagna                
Name: Robert Castagna
Title:   VP and Treasurer

Signature Page to First Amendment to Revolving Credit Agreement, dated as of April 10, 2015, for Boston Scientific

JPMORGAN CHASE BANK, N.A. 
as Administrative Agent and as a Lender

By: /s/ Vanessa Chiu 
Name: Vanessa Chiu 
Title:   Executive Director

Signature Page to First Amendment to Revolving Credit Agreement, dated as of April 10, 2015, for Boston Scientific

BANK OF AMERICA, N.A.,
as a Lender

By: /s/ Brian J. Walsh 
Name: Brian J. Walsh 
Title:   Vice President

Signature Page to First Amendment to Revolving Credit Agreement, dated as of April 10, 2015, for Boston Scientific

Barclays Bank PLC.,
as a Lender

By: /s/ Daniel Hunter  
Name: Daniel Hunter 
Title:   Assistant Vice President

Signature Page to First Amendment to Revolving Credit Agreement, dated as of April 10, 2015, for Boston Scientific

BNP Paribas,
as a Lender

By: /s/ Christopher Sked  
Name: Christopher Sked 
Title:   Managing Director

By: /s/ Ade Adedeji          
Name: Ade Adedeji 
Title:   Vice President

Signature Page to First Amendment to Revolving Credit Agreement, dated as of April 10, 2015, for Boston Scientific

CITIBANK, N.A.,
as a Lender

By: /s/ Marni McManus         
Name: Marni McManus 
Title:   Vice President

Signature Page to First Amendment to Revolving Credit Agreement, dated as of April 10, 2015, for Boston Scientific

DEUTSCHE BANK AG NEW YORK BRANCH,
as a Lender

By: /s/ Ming K. Chu         Name: Ming K. Chu 
Title:   Vice President

By: /s/ Heidi Sandquist         
Name: Heidi Sandquist 
Title:   Director

Signature Page to First Amendment to Revolving Credit Agreement, dated as of April 10, 2015, for Boston Scientific

ROYAL BANK OF CANANDA,
as a Lender

By: /s/ Steven Bachman                   
Name: Steven Bachman 
Title:   Authorized Signatory

Signature Page to First Amendment to Revolving Credit Agreement, dated as of April 10, 2015, for Boston Scientific

Sumitomo Mitsui Banking Corporation,
as a Lender

By: /s/ David W. Kee           
Name: David W. Kee 
Title:   Managing Director

Signature Page to First Amendment to Revolving Credit Agreement, dated as of April 10, 2015, for Boston Scientific

HSBC Bank USA, N.A,
as a Lender

By: /s/ Robert Moravec           
Name: Robert Moravec 
Title:   Vice President

Signature Page to First Amendment to Revolving Credit Agreement, dated as of April 10, 2015, for Boston Scientific

INTESA SANPAOLO S.p.A – New York Branch,
as a Lender

By: /s/ William S. Denton 
Name: William S. Denton 
Title:   Global Relationship Manager

By: /s/ Francesco Di Mario            
Name: Francesco Di Mario 
Title:   F.V.P. & Head of Credit

Signature Page to First Amendment to Revolving Credit Agreement, dated as of April 10, 2015, for Boston Scientific

Santander Bank, N.A.,
as a Lender

By: /s/ Thomas Bruscino         
Name: Thomas Bruscino 
Title:   Managing Director

Signature Page to First Amendment to Revolving Credit Agreement, dated as of April 10, 2015, for Boston Scientific

Standard Chartered Bank,
as a Lender

By: /s/ Pramita Saha             
Name: Pramita Saha 
Title:   Executive Director

Signature Page to First Amendment to Revolving Credit Agreement, dated as of April 10, 2015, for Boston Scientific

U.S. Bank National Association,
as a Lender

By: /s/ Michael West        
Name: Michael West 
Title:   Vice President

Signature Page to First Amendment to Revolving Credit Agreement, dated as of April 10, 2015, for Boston Scientific

Wells Fargo Bank N.A.,
as a Lender

By: /s/ Matthew Olson             
Name: Matthew Olson 
Title:   Director

Signature Page to First Amendment to Revolving Credit Agreement, dated as of April 10, 2015, for Boston Scientific

The Bank of Nova Scotia,
as a Lender

By: /s/ Michelle C. Phillips                 
Name: Michelle C. Phillips 
Title:   Execution Head & Director

Signature Page to First Amendment to Revolving Credit Agreement, dated as of April 10, 2015, for Boston Scientific

DNB Capital LLC,
as a Lender

By: /s/ Geshu Sugandh              
Name: Geshu Sugandh 
Title:   First Vice President

By: /s/ Bjorn E. Hammerstad   
Name: Bjorn E. Hammerstad 
Title:   Senior Vice President

Signature Page to First Amendment to Revolving Credit Agreement, dated as of April 10, 2015, for Boston Scientific

Danske Bank A/S,
as a Lender

By: /s/ Jorgen Linnet         
Name: Jorgen Linnet 
Title:   Chief Loan Manager

By: /s/ Gert Carstens            
Name: Gert Carstens 
Title:   Senior Loan Manager

Signature Page to First Amendment to Revolving Credit Agreement, dated as of April 10, 2015, for Boston Scientific

Allied Irish Banks p.l.c.,
as a Lender

By: /s/ Caroline Carney       
Name: Caroline Carney 
Title:   Relationship Manager

By: /s/ Conor Brogan            
Name: Conor Brogan 
Title:   Relationship Manager

Signature Page to First Amendment to Revolving Credit Agreement, dated as of April 10, 2015, for Boston Scientific

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00254-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00254-of-00352.parquet"}]]